PN 76103
RN 00457 
AN 77007715
AU Wright-P-F.  Khaw-K-T.  Oxman-M-N.  Shwachman-H.
TI Evaluation of the safety of amantadine-HC1 and the role of
   respiratory viral infections in children with cystic fibrosis.
SO J-Infect-Dis. 1976 Aug. 134(2). P 144-9.
MJ AMANTADINE: tu.  CYSTIC-FIBROSIS: co.  INFLUENZA: pc.
   RESPIRATORY-TRACT-INFECTIONS: pc.  VIRUS-DISEASES: pc.
MN ADOLESCENCE.  ADULT.  AMANTADINE: ae.  CHILD.  CHILD-PRESCHOOL.
   CLINICAL-TRIALS.  FEMALE.  HUMAN.  INFANT.  MALE.  PLACEBOS.
   RESPIRATORY-TRACT-INFECTIONS: et.  SUPPORT-U-S-GOVT-P-H-S.
   VIRUS-DISEASES: et.
AB Amantadine-HC1, an antiviral drug clinically effective against most
   strains of influenza A virus, was evaluated in a double-blind trial
   in 153 children with cystic fibrosis during the initial appearance of
   influenza A/England/42 virus in the New England area. Infection with
   this variant strain of influenza virus did not reach epidemic
   proportions during the study, so that the effectiveness of amantadine
   in this study population could not be fully assessed. However, the
   potential symptomatic and biochemical toxicity of amantadine was
   carefully monitored in a pediatric population. Serologic screening by
   complement fixation tests indicated that respiratory viruses may be
   important pathogens in exacerbations of respiratory disease in
   patients with cystic fibrosis.
RF 001   DAVIES WL             SCIENCE                        144   862 964
   002   TOGO Y                JAMA                           203  1089 968
   003   SMORODINSTSEV AA      JAMA                           213  1448 970
   004   WINGFIELD WL          N ENGL J MED                   281   579 969
   005   ANON                  AAP COMMITTEE INFECT DIS REPT        140 974
   006   QUILLIGAN JJ JR       J PEDIATR                       69   572 969
   007   ANON                  RECOMMENDED METHOD FOR THE US            971
   008   SEVER JL              J IMMUNOL                       88   320 962
   009   BIANDRATE P           J CHROMATOGR                    74    31 972
   010   ANON                  INFLUENZA RESPIRATORY DISEASE            974
   011   KATTWINKEL J          J PEDIATR                       82   234 973
   012   BLEIDNER WE           J PHARMACOL EXP THER           150   484 965
   013   MCLAREN C             LANCET                           1  1157 973
   014   CHANOCK RM            JAMA                           176   647 961
CT   1   HOIBY N               ACTA PATH MICROBIOL SCAND (C) S262     3 977
     2   TERMEULEN V           MONATSSCHR KINDERHEILKD        127   367 979
     3   GLEZEN WP             REV INFECT DIS                   2   408 980
     4   BECKER Y              PROG MED VIROL                  26     1 980
     5   FISHAUT M             AM J DIS CHILD                 134   321 980
     6   FEIGELSON J           NOUV PRESSE MED                 10   955 981
     7   HALL CB               AM J MED                        70   670 981
     8   PETERSEN NT           ACTA PAEDIATR SCAND             70   623 981
     9   GLEZEN WP             PEDIATR RES                     17  1029 983
    10   AMBROSINI PJ          J CLIN PSYCHOPHARMACOL           4   223 984
    11   EFTHIMIOU J           THORAX                          39   150 984
    12   WANG EEL              N ENGL J MED                   311  1653 984
    13   MISCHLER EH           SEM RESPIR MED                   6   271 985
    14   SHIELDS WD            NEUROLOGY                       35   579 985
    15   FRIEND PA             J INFECT                        13    55 986
    16   STROOBANT J           J ROY SOC MED                   79    19 986
    17   WANG EEL              PEDIATR INFECT DIS J             6   256 987
    18   THOMPSON J            J MED VIROL                     21   249 987